Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better
Cardinal Health (CAH) shares are up 10% year-to-date but down 8% since September. Jim Cramer suggested the decline may be due to a rotation into AI stocks. CAH's Q4 earnings beat estimates, with revenue of $63.67B, though missing expectations. Danaher (DHR) shares are down 7% year-to-date, with Q2 earnings beating estimates but deferring $100M in revenue. CAH's forward P/E is 18.48, lower than DHR's 22.47.
How this was made
The 30-second read
Why it matters
Both companies' recent earnings have already been priced in; the piece offers no new data to shift market expectations.
Market read
Recap of earnings and guidance with no fresh catalyst; limited trading relevance.
What to watch
Potential effects of the Inflation Reduction Act on CAH pricing and Danaher’s deferred revenue strategy.
Background
The article compares Cardinal Health and Danaher performance following recent earnings releases and analyst commentary.
Ticker impact
Cardinal Health's Q4 earnings and FY2027 guidance were recapped, showing EPS beat and revenue miss.
Limited short-term movement expected.
Recap of already‑published earnings provides little actionable insight.
Danaher’s Q2 earnings deferment and lowered revenue growth guidance were discussed as a performance drag.
Minimal impact; investors have likely adjusted.
Article restates known earnings details without new data.
Market effects
Healthcare sector sentiment unchanged; both firms already reflected earnings outcomes.
U.S. market impact minimal; no broader macro link.
Limited; only relevant to investors tracking CAH and DHR.
Counterpoint
If investors believe the earnings miss is temporary, a short‑term bounce could be possible.
Key entities
- CompanyCardinal Health
Healthcare services and products distributor.
- CompanyDanaher Corporation
Diversified science and technology firm.